Read More

Baudax Bio Announces Distribution Of Dividend Of One One-Thousandth Of A Share Series B Preferred Stock To Holders Of Its Common Stock For Each Outstanding Share Held Of Record As Of September 29

MALVERN, Pa., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for acute care settings, today